Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection

Robert L. Kruse, Xavier Legras, Mercedes Barzi

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

New therapies against hepatitis B virus (HBV) require the elimination of covalently closed circular DNA (cccDNA), the episomal HBV genome. HBV plasmids containing an overlength 1.3-mer genome and bacterial backbone (pHBV1.3) are used in many different models, but do not replicate the unique features of cccDNA. Since the stable cccDNA pool is a barrier to HBV eradication in patients, we developed a recombinant circular HBV genome (rcccDNA) to mimic the cccDNA using Cre/LoxP technology. We validated four LoxP insertion sites into the HBV genome using hydrodynamic tail vein injection into murine liver, demonstrating high levels of HBV surface antigen (HBsAg) and HBV DNA expression with rcccDNA formation. HBsAg expression from rcccDNA was >30,000 ng/mL over 78 days, while HBsAg-expression from pHBV1.3 plasmid DNA declined from 2753 ng/mL to 131 ng/mL over that time in immunodeficient mice (P < 0.001), reflective of plasmid DNA silencing. We then cloned Cre-recombinase in cis on the LoxP-HBV plasmids, achieving plasmid stability in bacteria with intron insertion into Cre and demonstrating rcccDNA formation after transfection in vitro and in vivo. These cis-Cre/LoxP-HBV plasmids were then used to create HBx-mutant and GFP reporter plasmids to further probe cccDNA biology and antiviral strategies against cccDNA. Overall, we believe these auto-generating rcccDNA plasmids will be of great value to model cccDNA for testing new therapies against HBV infection.

Original languageEnglish (US)
Article number198224
JournalVirus Research
Volume292
DOIs
StatePublished - Jan 15 2021
Externally publishedYes

Keywords

  • Cre/LoxP
  • Drug discovery
  • HBV
  • cccDNA

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Cancer Research

Fingerprint

Dive into the research topics of 'Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection'. Together they form a unique fingerprint.

Cite this